Open June 22, 2022 through Saturday, Dec 31, 2022 at 11:59pm (Pacific Time)
The Department of Pathology offers a one-year fellowship program in hematopathology. The purpose of this fellowship is to provide advanced training in hematopathology using state of the art supportive diagnostic techniques, in a broad spectrum of pediatric and adult morphologic hematopathology, including disorders of the bone marrow, peripheral blood, lymph node and other solid tissues, and coagulation. The fellow will gain experience in laboratory management in hematology, flow cytometry, and molecular diagnostics laboratories and in consulting on hematology patients.
Clinical material includes both UCLA patient cases as well as hematopathology consult cases. Numerous teaching conferences supplement our clinical workload. Fellows will be exposed to a full range of techniques: flow cytometry, DNA content analysis, immunoperoxidase procedures, FISH, conventional karyotyping, and other molecular/genetic diagnostic studies; the fellow will become proficient with the integration of specialized testing into diagnostic decision-making. Research opportunities in basic and clinical problems in hematopathology are available. A Department of Pathology endowed training grant fund is available to support translational research projects and educational travel.
The University of California is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability, age or protected veteran status. For the complete University of California nondiscrimination and affirmative action policy see:
UC Nondiscrimination & Affirmative Action Policy.
These positions are open to applicants who have completed training in a US or Canadian ACGME accredited AP/CP or AP only or CP only residency program. Applicant must be Board eligible or Board certified. International medical school graduates will only be considered if they have completed residency training in a US or Canadian ACGME accredited residency program. A California medical license is required on day one of appointment.
Fellowship Application - The fellowship application can be found at
Curriculum Vitae - Your most recently updated C.V.
Letter of Good Standing - Letter of good standing from your current Program Director. Please note, if one of your letter of recommendations is from your current Program Director, they will still need to write a separate letter of good standing.
USMLE Steps I, II, III
- 3-5 letters of reference required
Letters of recommendation
3 required; 2 optional
Help contact: email@example.com
As a condition of employment, you will be required to comply with the University of California SARS-CoV-2 (COVID-19) Vaccination Program Policy. All Covered Individuals under the policy must provide proof of Full Vaccination or, if applicable, submit a request for Exception (based on Medical Exemption, Disability, and/or Religious Objection) or Deferral (based on pregnancy) no later than the applicable deadline. New University of California employees must (a) provide proof of receiving at least one dose of a COVID-19 Vaccine no later than 14 calendar days after their first date of employment and provide proof of Full Vaccination no later than eight weeks after their first date of employment; or (b) if applicable, submit a request for Exception or Deferral no later than 14 calendar days after their first date of employment. (Capitalized terms in this paragraph are defined in the policy.) Federal, state, or local public health directives may impose additional requirements.
The University of California is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age or protected veteran status. For the complete University of California nondiscrimination and affirmative action policy, see: UC Nondiscrimination & Affirmative Action Policy.